|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Departments of Pneumology (Dr. Vendrell) and Biostatistics (Dr. Garcia), Hospital Josep Trueta, Girona; and Departments of Pneumology (Drs. de Gracia, Alvarez, and Miravitlles) and Immunology (Drs. Rodrigo and Cruz), Hospital Universitari Vall dHebron, Barcelona, Spain.
Correspondence to: Montserrat Vendrell, MD, Ps Canalejas n°1 esc 3 3°1, Girona 17001, Spain, e-mail: mont2188{at}separ.es
Background: No defined cause of bronchiectasis is currently found in approximately 50% of cases. Bronchiectasis is a common long-term complication in patients with primary hypogammaglobulinemia.
Study objectives: To ascertain whether antibody production deficiency with normal total serum IgG levels is associated with bronchiectasis.
Design: Antibody response to a pneumococcal unconjugate vaccine and an Haemophilus influenzae type b conjugate vaccine was prospectively studied in all consecutive adult patients with bronchiectasis of unknown etiology who were assessed in our chest outpatient clinic from January 1994 to October 2001. Serum-specific antibodies were measured by enzyme-linked immunosorbent assay, and the results were compared with those obtained in a healthy adult control group. Antibody production deficiency was defined as a failure to respond to either vaccine.
Results: One hundred seven patients were included in the study (mean age, 46.3 years). Antibody production deficiency was diagnosed in 12 patients (11%). A significantly higher incidence of otitis media, lower serum IgG2 subclass levels, and lower preimmunization antibody levels to Streptococcus pneumoniae and H influenzae type b were observed in patients with antibody production deficiency. The probability of antibody production deficiency in patients with a history of otitis media was 20%, 26% in those with low IgG2 subclass levels, and 58% in those with both a history of otitis media and low IgG2 subclass levels.
Conclusions: Antibody production deficiency with normal IgG levels may be associated with bronchiectasis, making it advisable to evaluate the antibody response to both the H influenzae and pneumococcal vaccines in patients with bronchiectasis of unknown etiology, particularly in those with a history of otitis media, low IgG2 subclass levels, and low levels of baseline specific antibodies.
Key Words: antibody deficiency bronchiectasis Haemophilus influenzae type b vaccine pneumococcal vaccine primary immunodeficiency
This article has been cited by other articles:
![]() |
M. Miravitlles, M. Vendrell, and J. de Gracia Antibody deficiency in bronchiectasis Eur. Respir. J., July 1, 2005; 26(1): 178 - 180. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |